Author Correction: Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Shivshankar Thanigaimani, James Phie, Smriti Murali Krishna, Joseph Moxon, Jonathan Golledge |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d828e3a20df4a67bf0f5dc28073699e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
por: Shivshankar Thanigaimani, et al.
Publicado: (2021) -
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Gian Luca Erre, et al.
Publicado: (2019) - Rheumatic Fever & Rheumatic Heart Disease
-
Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
por: Imperiali Claudia E., et al.
Publicado: (2020) -
Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
por: Fang-Ju Lin, et al.
Publicado: (2017)